How to use Bleomycin A5 (cas 11116-32-8) for infantile maxillofacial haemangiomas: Clinical evaluation of 82 consecutive cases
-
Add time:07/18/2019 Source:sciencedirect.com
ObjectiveBleomycin A5 (cas 11116-32-8) has been reported effective for infantile haemangioma (IH), but the usage and complications were described a little. We have used bleomycin A5 to treat maxillofacial IHs for 15 years. This paper describes the procedures to use bleomycin A5 and avoid its complications based on our clinical practices.
We also recommend Trading Suppliers and Manufacturers of Bleomycin A5 (cas 11116-32-8). Pls Click Website Link as below: cas 11116-32-8 suppliers
Prev:Modeling of molybdenum transport and pressure drop increase in fixed bed reactors used for selective oxidation of methanol to formaldehyde using iron molybdate catalysts
Next:Bleomycin A5 (cas 11116-32-8) sclerotherapy for cervicofacial lymphatic malformations) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma07/23/2019
- A clinical study of ultrasound-guided intralesional injection of Bleomycin A5 (cas 11116-32-8) on venous malformation in cervical-facial region in China07/22/2019
- Electrophoresis mobility shift assay and biosensor used in studying the interaction between Bleomycin A5 (cas 11116-32-8) and DNA07/20/2019
- Bleomycin A5 (cas 11116-32-8) plus dexamethasone for control of growth in infantile parotid hemangiomas07/21/2019
- Bleomycin A5 (cas 11116-32-8) sclerotherapy for cervicofacial lymphatic malformations07/19/2019
-
Health and Chemical more >